The spectrum of neuro-COVID is broader than anticipated. Neurological disease in COVID-19 may be due to a direct attack of the virus, due to the immune response against the virus, secondary due to affection of the heart or arteries, or due to side effects from the treatment applied against COVID-19.
Goel K, Kumar A, Diwan S, Kohli S, Sachdeva HC, Ganapathy U, et al. Neurological manifestations of COVID-19: A series of seven cases. Indian J Crit Care Med 2021;25(2):219–223. DOI: 10.5005/jp-journals-10071-23723.
Fayed I, Pivazyan G, Conte AG, Chang J, Mai JC. Intracranial hemorrhage in critically ill patients hospitalized for COVID-19. J Clin Neurosci 2020;81:192–195. DOI: 10.1016/j.jocn.2020.08.026.
Kirschenbaum D, Imbach LL, Rushing EJ, Frauenknecht KBM, Gascho D, Ineichen BV, et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol Appl Neurobiol 2021:47(3):454–459. DOI: 10.1111/nan.12677.
Lang CN, Dettinger JS, Berchtold-Herz M, Utzolino S, Bemtgen X, Zotzmann V, et al. Intracerebral hemorrhage in COVID-19 patients with pulmonary failure: A propensity score-matched registry study. Neurocrit Care 2021:34:739–747. DOI: 10.1007/s12028-021-01202-7.
Cezar-Junior AB, Faquini IV, Silva JLJ, de Carvalho Junior EV, Lemos LEAS, Freire Filho JBM, et al. Subarachnoid hemorrhage and COVID-19: Association or coincidence? Medicine (Baltimore) 2020;99(51):e23862. DOI: 10.1097/MD.0000000000023862.
